Name (Synonyms) | Correlation | |
---|---|---|
D012859 | Sjogren's Syndrome NIH | 0.71 |
D001327 | Autoimmune Diseases NIH | 0.58 |
D015535 | Arthritis, Psoriatic NIH | 0.50 |
D008180 | Lupus Erythematosus, Systemic NIH | 0.41 |
D001168 | Arthritis NIH | 0.29 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0002960 | Autoimmunity HPO | 0.58 |
HP:0002725 | Systemic lupus erythematosus HPO | 0.41 |
HP:0001369 | Arthritis HPO | 0.29 |
There is one clinical trial.
This epidemiological, transversal, cohort study aims to determine the potential influence of an active long-term hydroxychloroquine intake over the prevalence of a history of symptoms evocative of a COVID-19 infection in patients with a history of systemic lupus erythematosus, rheumatoid arthritis, Sjogren's syndrome or psoriatic arthritis, during the epidemic period in France. The information is gathered using a standardized questionnaire, by phone call.
Description: Adjusted Odds Ratio measuring the association between an exposure to long-term hydroxychloroquine intake and a history of symptoms compatible with a COVID-19 infection.
Measure: Adjusted Odds Ratio Time: 4 months after inclusion